Race Oncology is a brand dedicated to advancing precision oncology and ensuring the safety of patients' hearts. Their primary focus is on improving the lives of cancer patients worldwide. With a team of experts, Race Oncology is committed to developing innovative solutions and therapies to fight against cancer.

They have developed Bisantrene, a small molecule anthracene-based chemotherapeutic, which has shown promising results in treating cancer. Race Oncology's management team and board of directors bring a wealth of experience and expertise to guide the brand. They regularly provide strategic updates, keeping shareholders informed about their progress and revisions to the corporate outlook.

The brand also shares the latest news on clinical programs and market assessments. Located in Sydney, Australia, Race Oncology welcomes inquiries and collaborations. They can be contacted through their website or by phone.

Stay updated with their latest news and developments by subscribing to their newsletter. Race Oncology is dedicated to making a difference in cancer care and is committed to the well-being of patients around the world